Singular Genomics Systems, Inc. (OMIC): Price and Financial Metrics
OMIC Price/Volume Stats
| Current price | $0.36 | 52-week high | $3.00 |
| Prev. close | $0.38 | 52-week low | $0.36 |
| Day low | $0.36 | Volume | 104,300 |
| Day high | $0.40 | Avg. volume | 219,455 |
| 50-day MA | $0.54 | Dividend yield | N/A |
| 200-day MA | $1.26 | Market Cap | 26.11M |
OMIC Stock Price Chart Interactive Chart >
OMIC POWR Grades
- OMIC scores best on the Sentiment dimension, with a Sentiment rank ahead of 47.82% of US stocks.
- OMIC's strongest trending metric is Stability; it's been moving down over the last 146 days.
- OMIC's current lowest rank is in the Quality metric (where it is better than 6.3% of US stocks).
OMIC Stock Summary
- SINGULAR GENOMICS SYSTEMS INC's stock had its IPO on May 27, 2021, making it an older stock than only 6.43% of US equities in our set.
- As for revenue growth, note that OMIC's revenue has grown 178.82% over the past 12 months; that beats the revenue growth of 96.58% of US companies in our set.
- In terms of volatility of its share price, OMIC is more volatile than 94.48% of stocks we're observing.
- If you're looking for stocks that are quantitatively similar to SINGULAR GENOMICS SYSTEMS INC, a group of peers worth examining would be LCTX, ONVO, MNTS, ALGM, and WATT.
- Visit OMIC's SEC page to see the company's official filings. To visit the company's web site, go to singulargenomics.com.
OMIC Valuation Summary
- In comparison to the median Healthcare stock, OMIC's price/earnings ratio is 101.12% lower, now standing at -0.3.
- Over the past 28 months, OMIC's price/earnings ratio has gone up 37.2.
Below are key valuation metrics over time for OMIC.
| Stock | Date | P/S | P/B | P/E | EV/EBIT |
|---|---|---|---|---|---|
| OMIC | 2023-09-22 | 13.1 | 0.1 | -0.3 | -0.1 |
| OMIC | 2023-09-21 | 13.5 | 0.1 | -0.3 | -0.1 |
| OMIC | 2023-09-20 | 12.7 | 0.1 | -0.3 | -0.1 |
| OMIC | 2023-09-19 | 13.0 | 0.1 | -0.3 | -0.1 |
| OMIC | 2023-09-18 | 13.5 | 0.1 | -0.3 | -0.1 |
| OMIC | 2023-09-15 | 14.3 | 0.1 | -0.3 | -0.1 |
OMIC Price Target
For more insight on analysts targets of OMIC, see our OMIC price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.
| Average Price Target | $30.33 | Average Broker Recommendation | 1.6 (Moderate Buy) |
Singular Genomics Systems, Inc. (OMIC) Company Bio
Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and multiomics technology to build products for researchers and clinicians to advance science and medicine. It manufactures G4 Instrument, a benchtop next generation sequencer to produce genetic sequencing results, as well as associated menu of consumable kits; and offers PX Integrated Solution that combines single cell analysis, spatial analysis, genomics and proteomics in one integrated instrument providing a versatile multiomics solution. The company was incorporated in 2016 and is headquartered in La Jolla, California.
Latest OMIC News From Around the Web
Below are the latest news stories about SINGULAR GENOMICS SYSTEMS INC that investors may wish to consider to help them evaluate OMIC as an investment opportunity.
Beware! 3 Biotech Stocks Waving Massive Red Flags Right NowThere are always many biotech stocks to avoid and these firms are among the clearest choices currently to steer clear of. |
Singular Genomics to Present at the Gilmartin Group Emerging Growth Company ShowcaseSAN DIEGO, Sept. 08, 2023 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians, today announced plans to participate in the virtual Gilmartin Group Emerging Growth Company Showcase. Singular Genomics’ management is scheduled to present on Thursday, September 21, 2023, at 8:30 a.m. Pacific Time / 11:30 a.m. Eastern Time. Investors and other interested partie |
Q2 2023 Singular Genomics Systems Inc Earnings CallQ2 2023 Singular Genomics Systems Inc Earnings Call |
Singular Genomics Reports Recent Highlights and Second Quarter 2023 Financial ResultsSAN DIEGO, Aug. 09, 2023 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians, today highlighted recent corporate achievements and reported financial results for the second quarter ended June 30, 2023. “We made significant advancements across our operations, manufacturing and commercial infrastructure, and saw growth in our sales funnel. In addition, we shi |
Singular Genomics Appoints Genomics Veteran Marcia Eisenberg, Ph.D., to Board of DirectorsSAN DIEGO, Aug. 08, 2023 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians, today announced the appointment of Marcia Eisenberg, Ph.D., to the Company’s Board of Directors. Dr. Eisenberg currently serves as Senior Vice President and Enterprise Chief Scientific Officer at Labcorp (NYSE: LH) and brings more than 30 years of experience with molecular geneti |
OMIC Price Returns
| 1-mo | -23.40% |
| 3-mo | -55.99% |
| 6-mo | -71.88% |
| 1-year | -85.60% |
| 3-year | N/A |
| 5-year | N/A |
| YTD | -82.09% |
| 2022 | -82.61% |
| 2021 | N/A |
| 2020 | N/A |
| 2019 | N/A |
| 2018 | N/A |
Loading social stream, please wait...